Global Glucose Monitoring Market Report: 2015 Edition
Diabetes, often referred to as diabetes mellitus, describes a group of metabolic diseases in which the person has high blood glucose (blood sugar), either because insulin production is inadequate, or because the body’s cells do not respond properly to insulin, or both. The high blood sugar produces the symptoms of frequent urination (polyuria), increased thirst (polydipsia), and increased hunger (polyphagia). Diabetes can cause acute complications which include diabetic ketoacidosis and nonketotic hyperosmolar coma. Serious long-term complications include heart disease, stroke, kidney failure, foot ulcers and damage to the eyes.
Blood Glucose Monitoring refers to the way of testing the concentration of glucose in the blood (glycemia). Monitoring blood sugar levels is an essential part of diabetes care, as waiting for symptoms of extremely high or low blood sugar levels can result in life threatening situations. Blood sugar monitoring is done with devices which obtain a drop of blood from a finger prick, which is then analyzed on a reagent strip. The test is generally referred to as capillary blood glucose.
The key factors which are anticipated to drive the market include factors like increasing aging population, rising healthcare expenditure, increasing urbanization, obese population and awareness about blood glucose monitoring. Some of the noteworthy developments of this industry include sedentary lifestyle, increasing prevalence of diabetes, among others. However, the growth of respective industry is hindered by the barriers of regulatory risk, intense competition, and non-invasive blood glucose monitoring, among others.
This report offers a comprehensive analysis of the global glucose monitoring industry. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global glucose monitoring market is reined by few major players namely, Johnson and Johnson, Bayer, Roche and Abbott. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
Blood Glucose Monitoring refers to the way of testing the concentration of glucose in the blood (glycemia). Monitoring blood sugar levels is an essential part of diabetes care, as waiting for symptoms of extremely high or low blood sugar levels can result in life threatening situations. Blood sugar monitoring is done with devices which obtain a drop of blood from a finger prick, which is then analyzed on a reagent strip. The test is generally referred to as capillary blood glucose.
The key factors which are anticipated to drive the market include factors like increasing aging population, rising healthcare expenditure, increasing urbanization, obese population and awareness about blood glucose monitoring. Some of the noteworthy developments of this industry include sedentary lifestyle, increasing prevalence of diabetes, among others. However, the growth of respective industry is hindered by the barriers of regulatory risk, intense competition, and non-invasive blood glucose monitoring, among others.
This report offers a comprehensive analysis of the global glucose monitoring industry. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global glucose monitoring market is reined by few major players namely, Johnson and Johnson, Bayer, Roche and Abbott. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future of the market. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.
1. INTRODUCTION
1.1 Diabetes
1.2 Blood Glucose Monitoring
2. MARKET ANALYSIS
2.1 Global Diabetes Devices Market
Market Overview
Market Segmentation
2.2 Global Glucose Monitoring Market
2.2.1 Traditional Glucose Monitoring Market
Market Value
Regional Breakdown
2.2.2 Continuous Glucose Monitoring Market
Market Value
Regional Breakdown
Market Opportunity by Region
2.3 The US Glucose Monitoring Market
Market Value
CGM Penetration
Growth of Type 1 CGM Users
3. MARKET DYNAMICS
3.1 Key Trends
3.1.1 Sedentary Lifestyle
3.1.2 Increasing Prevalence of Diabetes in Children
3.1.3 Growing Number of Global Diabetic Patients
3.1.4 Finger Stick Replacement – A potential Game-Changer
3.1.5 CGM Recommendation Gaining Importance Worldwide
3.2 Significant Developments
3.2.1 FreeStyle Libre Launched by Abbott
3.2.2 Dexcom Launched G4 PLATINUM CGM
3.2.3 Accu-Check Nano SmartView Launched by Roche
3.2.4 Wearable Semi-Invasive Blood Sampling Devices for CGM
3.3 Growth Drivers
3.3.1 Accelerating Aging Population
3.3.2 Increasing Urbanization
3.3.3 Rising Obese Population
3.3.4 Increasing Healthcare Expenditure
3.3.5 Awareness about Glucose Monitoring
3.4 Challenges
3.4.1 Intense Competition
3.4.2 Regulatory Risk
3.4.3 Non-invasive Glucose Monitoring
3.4.4 Inadequate Reimbursement and Coverage
4. COMPETITIVE LANDSCAPE
Market Share
Device Comparison
5. COMPANY PROFILES
5.1 Johnson and Johnson
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Creating Value through Innovation
Increasing Global Reach
5.2 Abbott Laboratories
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Business Diversification
Expansion through Acquisitions
5.3 Roche Holdings AG
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Strengthening through Acquisitions
Ceaseless Focus on R&D
5.4 Bayer AG
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Expanding Product Portfolio
Step up Investment in R&D
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
1.1 Diabetes
1.2 Blood Glucose Monitoring
2. MARKET ANALYSIS
2.1 Global Diabetes Devices Market
Market Overview
Market Segmentation
2.2 Global Glucose Monitoring Market
2.2.1 Traditional Glucose Monitoring Market
Market Value
Regional Breakdown
2.2.2 Continuous Glucose Monitoring Market
Market Value
Regional Breakdown
Market Opportunity by Region
2.3 The US Glucose Monitoring Market
Market Value
CGM Penetration
Growth of Type 1 CGM Users
3. MARKET DYNAMICS
3.1 Key Trends
3.1.1 Sedentary Lifestyle
3.1.2 Increasing Prevalence of Diabetes in Children
3.1.3 Growing Number of Global Diabetic Patients
3.1.4 Finger Stick Replacement – A potential Game-Changer
3.1.5 CGM Recommendation Gaining Importance Worldwide
3.2 Significant Developments
3.2.1 FreeStyle Libre Launched by Abbott
3.2.2 Dexcom Launched G4 PLATINUM CGM
3.2.3 Accu-Check Nano SmartView Launched by Roche
3.2.4 Wearable Semi-Invasive Blood Sampling Devices for CGM
3.3 Growth Drivers
3.3.1 Accelerating Aging Population
3.3.2 Increasing Urbanization
3.3.3 Rising Obese Population
3.3.4 Increasing Healthcare Expenditure
3.3.5 Awareness about Glucose Monitoring
3.4 Challenges
3.4.1 Intense Competition
3.4.2 Regulatory Risk
3.4.3 Non-invasive Glucose Monitoring
3.4.4 Inadequate Reimbursement and Coverage
4. COMPETITIVE LANDSCAPE
Market Share
Device Comparison
5. COMPANY PROFILES
5.1 Johnson and Johnson
5.1.1 Business Overview
5.1.2 Financial Overview
5.1.3 Business Strategies
Creating Value through Innovation
Increasing Global Reach
5.2 Abbott Laboratories
5.2.1 Business Overview
5.2.2 Financial Overview
5.2.3 Business Strategies
Business Diversification
Expansion through Acquisitions
5.3 Roche Holdings AG
5.3.1 Business Overview
5.3.2 Financial Overview
5.3.3 Business Strategies
Strengthening through Acquisitions
Ceaseless Focus on R&D
5.4 Bayer AG
5.4.1 Business Overview
5.4.2 Financial Overview
5.4.3 Business Strategies
Expanding Product Portfolio
Step up Investment in R&D
6. MARKET OUTLOOK
6.1 Market Forecast
6.2 Forecast Methodology
6.2.1 Dependent and Independent Variables
6.2.2 Correlation Analysis
6.2.3 Regression Analysis
LIST OF CHARTS
Types of Diabetes
Types of Glucose Meters
Glucose Monitoring Market
Global Diabetes Devices Market by Segments (2013)
Diabetes Equipment Market in Emerging Nations (2009-2015E)
Global Total Glucose Monitoring Market (2005-2013)
Global Traditional Glucose Monitoring Market (2005-2015E)
Market Share Composition of Glucose Monitoring Systems (2013)
Traditional Glucose Monitoring Market by Geography (2014E)
Global Continuous Glucose Monitoring Market (2005-2015E)
Continuous Glucose Monitoring Market by Geography (2014E)
Market Opportunity for CGM-Type 1 Diabetics by Geography (2014E)
Market Opportunity for CGM-Type 2 Diabetics by Geography (2014E)
The US Glucose Monitoring Market (2008-2015E)
The US CGM Penetration of Type 1 Diabetics (2010-2013)
Number and Annual Growth of Type 1 Diabetes CGM Users in the US (2012-2016E)
No. of Children (0-14 years) with Type 1 Diabetes by Region (2013)
Outlook for Global Diabetic Patients (2010-2030)
% of Patients Expected to Adopt CGM Based on Features (2014E)
Global Ageing Population (2008-2013)
Global Urban Population (2008-2013)
Growth in Worldwide Obese Population (2004-2013E)
Global Healthcare Expenditure per Capita (2007-2013)
Global Glucose Monitoring Market by Company (2014E)
Global Continuous Glucose Monitoring Market by Company (2014E)
US Type 1 CGM Market Share by Company (2014E)
Sales of Johnson & Johnson’s by Business Segments (2013)
Revenues and Net Income of Johnson & Johnson (2009-2013)
Abbott Laboratories Revenue Share by Business Unit (2013)
Abbott Laboratories Revenue and Net Income (2009-2013)
Roche’s Revenue Share by Division (2013)
Roche’s Revenue and Net Income (2009-2013)
Bayer AG Revenue Share by Business Segments (2013)
Bayer’s Revenue and Net Income (2009-2013)
Global Total Glucose Monitoring Market (2010-2017E)
Types of Diabetes
Types of Glucose Meters
Glucose Monitoring Market
Global Diabetes Devices Market by Segments (2013)
Diabetes Equipment Market in Emerging Nations (2009-2015E)
Global Total Glucose Monitoring Market (2005-2013)
Global Traditional Glucose Monitoring Market (2005-2015E)
Market Share Composition of Glucose Monitoring Systems (2013)
Traditional Glucose Monitoring Market by Geography (2014E)
Global Continuous Glucose Monitoring Market (2005-2015E)
Continuous Glucose Monitoring Market by Geography (2014E)
Market Opportunity for CGM-Type 1 Diabetics by Geography (2014E)
Market Opportunity for CGM-Type 2 Diabetics by Geography (2014E)
The US Glucose Monitoring Market (2008-2015E)
The US CGM Penetration of Type 1 Diabetics (2010-2013)
Number and Annual Growth of Type 1 Diabetes CGM Users in the US (2012-2016E)
No. of Children (0-14 years) with Type 1 Diabetes by Region (2013)
Outlook for Global Diabetic Patients (2010-2030)
% of Patients Expected to Adopt CGM Based on Features (2014E)
Global Ageing Population (2008-2013)
Global Urban Population (2008-2013)
Growth in Worldwide Obese Population (2004-2013E)
Global Healthcare Expenditure per Capita (2007-2013)
Global Glucose Monitoring Market by Company (2014E)
Global Continuous Glucose Monitoring Market by Company (2014E)
US Type 1 CGM Market Share by Company (2014E)
Sales of Johnson & Johnson’s by Business Segments (2013)
Revenues and Net Income of Johnson & Johnson (2009-2013)
Abbott Laboratories Revenue Share by Business Unit (2013)
Abbott Laboratories Revenue and Net Income (2009-2013)
Roche’s Revenue Share by Division (2013)
Roche’s Revenue and Net Income (2009-2013)
Bayer AG Revenue Share by Business Segments (2013)
Bayer’s Revenue and Net Income (2009-2013)
Global Total Glucose Monitoring Market (2010-2017E)
LIST OF TABLES
Blood Glucose Range for People with diabetes
Diabetes Prevalence in the US (2010-2013E)
Worldwide Market Opportunity for CGM by Value (2014E)
Estimated US Market for ICU Continuous Glucose Monitoring
Most Important Factors Driving CGM Recommendation
CGM Device Comparison
Dependent & Independent Variables (2009–2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
Blood Glucose Range for People with diabetes
Diabetes Prevalence in the US (2010-2013E)
Worldwide Market Opportunity for CGM by Value (2014E)
Estimated US Market for ICU Continuous Glucose Monitoring
Most Important Factors Driving CGM Recommendation
CGM Device Comparison
Dependent & Independent Variables (2009–2013)
Correlation Matrix
Model Summary – Coefficient of Determination
Regression Coefficients Output
